[go: up one dir, main page]

AR071917A1 - Vacunas contra la coccidiosis - Google Patents

Vacunas contra la coccidiosis

Info

Publication number
AR071917A1
AR071917A1 ARP090101891A ARP090101891A AR071917A1 AR 071917 A1 AR071917 A1 AR 071917A1 AR P090101891 A ARP090101891 A AR P090101891A AR P090101891 A ARP090101891 A AR P090101891A AR 071917 A1 AR071917 A1 AR 071917A1
Authority
AR
Argentina
Prior art keywords
strain
animal
against coccidiosis
vaccines against
species
Prior art date
Application number
ARP090101891A
Other languages
English (en)
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of AR071917A1 publication Critical patent/AR071917A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicacion 1: Una composicion de vacuna que comprende una primera cepa de una especie del genero de Coccidia y una segunda cepa de dicha especie; en la cual la primera cepa y la segunda cepa tienen un per¡odo prepatente asincronico. Reivindicacion 2: La vacuna de acuerdo con la reivindicacion 1 en la cual el genero es seleccionado del grupo que consiste en Isospora, Cystoisospora, Cryptosporidium, y Eimeria. Reivindicacion 20: Un metodo para inmunizar a un sujeto animal contra la coccidiosis, que comprende administrar al animal una cantidad efectiva desde el punto de vista inmunologico de la vacuna de acuerdo con la reivindicacion 1. Reivindicacion 24: El metodo de acuerdo con la reivindicacion 20 en el cual el animal es un ave domestica.
ARP090101891A 2008-05-29 2009-05-27 Vacunas contra la coccidiosis AR071917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5700308P 2008-05-29 2008-05-29

Publications (1)

Publication Number Publication Date
AR071917A1 true AR071917A1 (es) 2010-07-21

Family

ID=41254633

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101891A AR071917A1 (es) 2008-05-29 2009-05-27 Vacunas contra la coccidiosis

Country Status (14)

Country Link
US (1) US9050281B2 (es)
EP (1) EP2296698A1 (es)
JP (1) JP2011521955A (es)
CN (1) CN102046197A (es)
AR (1) AR071917A1 (es)
BR (1) BRPI0912263A2 (es)
CA (1) CA2725361C (es)
CO (1) CO6331298A2 (es)
IL (1) IL208660A0 (es)
MX (1) MX2010012869A (es)
PE (1) PE20100145A1 (es)
RU (1) RU2525587C2 (es)
TW (1) TW201010717A (es)
WO (1) WO2009148895A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070077256A1 (en) 1999-11-19 2007-04-05 Los Angeles Biomedical Research Institute Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents
BRPI0921843B1 (pt) * 2008-11-13 2020-11-24 Intervet International B.V. composição de vacina, e, uso de uma composição de vacina
US8858959B2 (en) 2011-07-15 2014-10-14 The United States Of America, As Represented By The Secretary Of Agriculture Gel vaccine delivery system for treating poultry
EP2734229B1 (en) 2011-07-22 2019-01-02 Novadigm Therapeutics, Inc. Methods and copositions for vaccinating against staphylococcus aureus
CA2906771A1 (en) 2013-03-15 2014-09-18 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Compositions and methods for treating fungal and bacterial pathogens
CN103251938B (zh) * 2013-04-15 2015-07-15 内蒙古神元生物工程股份有限公司 鸡艾美耳球虫弱毒疫苗产业化生产工艺
KR20250107959A (ko) 2015-11-13 2025-07-14 타르간 인크. 동물에 물질을 주입하기 위한 자동 시스템 및 방법
CN107019799A (zh) * 2016-01-30 2017-08-08 天津赫莱恩特生物科技有限公司 一种鸡球虫病四价弱毒活疫苗组合物在生产中的应用
CN107019704A (zh) * 2016-01-31 2017-08-08 天津赫莱恩特生物科技有限公司 提高鸡柔嫩艾美尔球虫疫苗免疫效果组合物的应用
CN107019111B (zh) * 2016-01-31 2020-11-20 天津赫莱恩特生物科技有限公司 提高巨型艾美尔球虫卵囊产量的组合物及其制备方法
WO2017155949A1 (en) 2016-03-09 2017-09-14 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Methods and kits for use in preventing and treating vulvovaginal candidiasis
US20180208885A1 (en) 2017-01-24 2018-07-26 Mary Ann Pfannenstiel Antibiotic-free compositions for the prevention or control of coccidiosis
CN107670032A (zh) * 2017-10-27 2018-02-09 贵州福斯特生物科技有限公司 家禽油乳剂灭活疫苗佐剂及其相应疫苗的制备方法
CN108060085A (zh) * 2017-12-31 2018-05-22 天津赫莱恩特生物科技有限公司 一种提高毒害艾美尔球虫卵囊纯化成功率的方法
EP3813876A1 (en) * 2018-07-10 2021-05-05 Applied Lifesciences and Systems, LLC Method of preparing and delivering oocyst solutions
CN109646674B (zh) * 2019-01-25 2022-08-09 中国农业大学 一种球虫病活疫苗及其应用
CN115461065A (zh) 2020-01-27 2022-12-09 普通益生菌股份有限公司 包含用于表达和分泌Enterocin以控制产气荚膜梭菌诱导的家畜坏死性肠炎的益生菌的组合物和相关方法
US20220401668A1 (en) * 2021-06-17 2022-12-22 Applied Lifesciences And Systems Llc Automatic System and Method for Injecting a Substance into an Animal
WO2023170057A1 (en) * 2022-03-08 2023-09-14 Hipra Scientific, S.L.U. In ovo vaccine compositions against coccidiosis
WO2025233315A1 (en) 2024-05-07 2025-11-13 Veterinärmedizinische Universität Wien Novel immunological composition against cystoisospora suis

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5649323A (en) * 1979-09-29 1981-05-02 Nisshin Flour Milling Co Ltd Coccidiostat
JPS5780325A (en) * 1980-09-05 1982-05-19 Nat Res Dev Coccidial disease vaccine
GB8326633D0 (en) 1983-08-04 1983-11-09 Unilever Plc Compositions
ES2129423T3 (es) * 1986-08-18 1999-06-16 Btg Int Ltd Vacunas.
US4935007A (en) * 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
IL83643A (en) 1986-08-28 1991-01-31 Lilly Co Eli Anticoccidial method
GB8711256D0 (en) 1987-05-13 1987-06-17 Unilever Plc Protection
ZA954785B (en) 1994-06-16 1996-02-08 Yamanouchi Pharma Co Ltd Crude drug-containing feed
MX9709870A (es) 1995-06-07 1998-03-31 Pfizer Uso de esporocistos u occistos para preparar una vacuna contra coccidiosis.
US6500438B2 (en) 1995-06-07 2002-12-31 Pfizer Incorporated In ovo vaccination against coccidiosis
CA2213385A1 (en) * 1997-08-20 1999-02-20 Eng-Hong Lee Method of protecting against coccidiosis infections in poultry
CA2214233A1 (en) * 1997-08-29 1999-02-28 Eng-Hong Lee Method for assessing viability of live microbial therapeutic agents
AUPP268398A0 (en) 1998-03-30 1998-04-23 Eimeria Pty Limited Vaccination modalitites
DE19828322A1 (de) 1998-06-25 1999-12-30 Hoechst Roussel Vet Gmbh Coccidienvakzine, Verfahren zu ihrer Herstellung und ihre Verwendung
US7247309B2 (en) * 1999-12-21 2007-07-24 Intervet International B.V. Coccidiosis vaccines
AUPQ622900A0 (en) 2000-03-15 2000-04-06 University Of Melbourne, The Pcr-based identification of eimeria species and strains
US6432646B1 (en) * 2000-03-16 2002-08-13 The University Of Melbourne PCR-based identification of Eimeria species and strains
US20020160022A1 (en) * 2000-11-08 2002-10-31 Schasteen Charles S. Methods and compositions for the control of coccidiosis
US6969602B1 (en) * 2001-04-20 2005-11-29 The United States Of America As Represented By The Secretary Of The Agriculture Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protection with other Eimeria maximas
CN1547607A (zh) 2001-08-30 2004-11-17 制备卵囊的改进方法
TWI348376B (en) 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
CA2486618C (en) * 2002-05-21 2013-04-09 Schering-Plough Ltd. Methods for the in vitro culture of sporozoea sp. and uses thereof
CA2498604A1 (en) 2002-09-20 2004-04-01 Akzo Nobel N.V. Live antenuated parasite vaccine
EP1569687B1 (en) 2002-12-09 2010-10-06 University Of Georgia Research Foundation, Inc. Coccidial vaccine and methods of making and using same
US7354593B2 (en) * 2002-12-09 2008-04-08 Merial Limited Coccidial vaccine and methods of making and using same
CA2559272C (en) 2004-03-12 2015-12-01 University Of Georgia Research Foundation, Inc. Novel peanut skin extract as a vaccine adjuvant
MX2007012784A (es) * 2005-04-15 2008-01-11 Univ Georgia Res Found Vacuna coccidial y metodos para elaborarla y usarla.
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
BRPI0921843B1 (pt) 2008-11-13 2020-11-24 Intervet International B.V. composição de vacina, e, uso de uma composição de vacina

Also Published As

Publication number Publication date
CO6331298A2 (es) 2011-10-20
MX2010012869A (es) 2010-12-14
RU2525587C2 (ru) 2014-08-20
WO2009148895A1 (en) 2009-12-10
IL208660A0 (en) 2010-12-30
CA2725361C (en) 2017-05-16
CN102046197A (zh) 2011-05-04
BRPI0912263A2 (pt) 2015-10-20
US20100015182A1 (en) 2010-01-21
CA2725361A1 (en) 2009-12-10
TW201010717A (en) 2010-03-16
RU2010153992A (ru) 2012-07-10
EP2296698A1 (en) 2011-03-23
US9050281B2 (en) 2015-06-09
PE20100145A1 (es) 2010-03-05
JP2011521955A (ja) 2011-07-28

Similar Documents

Publication Publication Date Title
AR071917A1 (es) Vacunas contra la coccidiosis
MX375202B (es) Composiciones adyuvantes novedosas.
MX351975B (es) Composiciones y metodos para el tratamiento de infecciones y tumores.
CL2016000650A1 (es) Composicion de vacuna que comprende un antigeno y una formulacion coadyuvante, que comprende al menos el 50 % v/v de una fase oleosa, monofosforil-lipido a (mpl-a) o un analogo del mismo y un oligonucleotido inmunoestimulate; y uso de la composición de vacuna para preparar un medicamento.
CO6511229A2 (es) Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada
MX2017014127A (es) Conjugados proteina-polisacarido de estreptococo grupo b, metodos para producir conjugados, composiciones inmunogenas que comprenden conjugados y sus usos.
AR083395A1 (es) Derivado peptidico nmu (neuromedina u) con elevado efecto anorectico
MY150855A (en) Oral compositions containing extracts of zizyphus joazeiro and related methods
CR11723A (es) Agente para tratar enfermedad
AR069882A1 (es) Circovirus porcino, molecula de acido nucleico aislada que lo codifica, composicion inmunogenica que lo comprende, vector que comprende por lo menos una molecula de acido nucleico exogena que codifica una proteina de circovirus porcino y metodos para inmunizar un cerdo contra la infeccion virica o e
BRPI0510430A (pt) composições e métodos para vacinação mucosal
CO2019000214A2 (es) Vacuna contra virus de bronquitis infecciosa
MX2013010620A (es) Adenovirus de aves del serotipo 4 (fadv-4) no patogénico y vector viral del mismo.
MY150829A (en) Oral compositions containing extracts of myristica fragrans and related methods
AR089509A1 (es) Metodo para tratar la perdida osea alveolar, un implante dental, un anticuerpo antiesclerostina, un gel o matriz que comprende dicho anticuerpo y uso
BR112014001409A2 (pt) métodos e composições para vacinação contra staphylococcus aureus
MX391930B (es) Vacuna contra la fiebre aftosa.
CR8638A (es) Vacuna agalactiae estreptococos
AR087911A1 (es) Metodos en multiples etapas y composiciones para desensibilizar las caras de formaciones subterraneas
CO6361950A2 (es) Composiciones, vacunas y metodos del virus del herpes del ganado bovino -1
UY39464A (es) Composiciones y métodos para la prevención y/o tratamiento de la covid-19
MX344544B (es) Vacuna para paludismo en etapa sanguinea.
BR112015010675A8 (pt) composição de higiene oral compreendendo copolímero de blocos e método para proteger esmalte dos dentes de erosão ácida”
MX2017007130A (es) Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo.
EA201290319A1 (ru) Применение источника l3 и/или l5 в качестве вакцины или диагностического средства для паразитарного заболевания

Legal Events

Date Code Title Description
FC Refusal